Table 1.
Patient | Age/sex | Diagnosis | Proximal muscle weakness | DM skin rash | ↑ Muscle enzymes | Anti-Jo1 antibodies | Abnormal EMG findings | Abnormal muscle biopsy findings | Medication |
---|---|---|---|---|---|---|---|---|---|
1 | 20/F | PM/MCTD | + | − | + | − | − | + | Pred., MTX |
2 | 46/F | PM | + | − | + | − | + | + | Pred., MTX |
3 | 31/F | PM | + | − | + | − | + | + | Pred., MTX |
4 | 65/F | PM | + | − | + | − | + | − | Pred., MTX |
5 | 47/F | PM/ILD | + | − | + | + | NR | + | Pred., MTX, IVIG |
6 | 72/H | PM | + | − | + | − | − | + | Pred. |
7 | 67/F | PM | + | − | + | − | + | + | Pred. |
8 | 27/F | PM/MCTD | + | − | + | − | + | − | Pred., AZA |
9 | 41/H | PM | + | − | + | + | + | + | Pred., MTX |
10 | 72/H | PM/HCV | + | − | + | − | + | + | Pred., IVIG |
11 | 61/F | PM | + | − | + | − | + | + | Pred. |
12 | 38/F | PM/ILD | + | − | + | + | + | + | Pred., MTX |
13 | 61/H | PM | + | − | + | − | + | − | Pred., MTX, IVIG |
14 | 57/F | PM/MCTD | + | − | + | − | + | + | Pred., MTX, chloroquine |
15 | 77/F | PM | + | − | + | − | + | + | Pred. |
16 | 63/H | PM/ILD | + | − | + | + | + | + | Pred. |
17 | 48/F | PM | + | − | + | − | + | − | Pred., MTX, IVIG, AZA |
18 | 37/H | DM | + | + | + | − | + | + | Pred., MTX |
19 | 42/F | DM | + | + | + | − | + | − | Pred., MTX, IVIG |
20 | 56/H | DM | + | + | + | − | + | − | Pred., MTX, chloroquine |
21 | 44/H | DM | + | + | + | − | + | − | Pred., MTX, IVIG |
22 | 14/F | DM | + | + | + | − | + | + | Pred. |
23 | 67/H | DM | + | + | + | − | + | + | Pred. |
24 | 40/F | DM | + | + | + | − | + | + | Pred., MTX |
25 | 40/F | DM | + | + | + | + | + | + | Pred., MTX, IVIG, AZA, CSA |
26 | 74/H | IBM | + | − | + | − | + | + | Pred. |
27 | 69/F | IBM | + | − | + | − | + | + | Pred., MTX, IVIG |
MCTD: mixed connective tissue disease; ILD: interstitial lung disease; HCV: hepatitis C virus; Pred.: prednisone; MTX: methotrexate; IVIG: intravenous immunoglobulin; AZA: azathioprine; CSA: cyclosporine; NR: not reported or not done.